Psilocybin therapeutic use program establishment

This bill establishes a regulated therapeutic program in Minnesota allowing adults aged 21 and older to use psilocybin under medical supervision for qualifying conditions such as PTSD, depression, and chronic pain. The program requires patients to be certified by a licensed physician and administered by registered facilitators who oversee preparation, administration, and integration sessions. Key provisions include creating an advisory committee, setting up data collection requirements, establishing fees, and defining criminal penalties for violations. The legislation authorizes the state health commissioner to implement rules and protections for patients, suppliers, facilitators, and healthcare practitioners involved in the program.